Company Filing History:
Years Active: 2024
Title: Angelo Pugliese: Innovator in Pharmaceutical Chemistry
Introduction
Angelo Pugliese is a notable inventor based in Scotland, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate glucocorticoid receptors. His work is essential for advancing therapeutic options in various medical conditions.
Latest Patents
Angelo Pugliese holds a patent for "Piperazine indazole glucocorticoid receptor antagonists." This patent includes piperazine substituted fused azadecalin compounds of Formula J, I, Ia, Ib, Ib-1, Ib-2, Ic, and Id. These compounds are designed for use in pharmaceutical formulations, specifically targeting the modulation of glucocorticoid receptors. He has 1 patent to his name.
Career Highlights
Pugliese is associated with Corcept Therapeutics Incorporated, a company known for its innovative approaches in the pharmaceutical industry. His work at Corcept Therapeutics has allowed him to focus on developing new therapeutic agents that can significantly impact patient care.
Collaborations
Throughout his career, Angelo has collaborated with talented professionals, including Mark Mills and Andrew William Phillips. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Angelo Pugliese is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for patients. His contributions, particularly in glucocorticoid receptor modulation, highlight the importance of innovation in medicine.